Austrian deep-tech company Sendance has secured fresh backing from Czech investor group Garage Angels as it advances its mission to transform assistive medical devices into intelligent data platforms. The Brno-based syndicate committed several hundred thousand euros through a convertible loan as part of Sendance’s ongoing third funding round. The round builds on earlier participation from Electron Capital Partners, which joined during the company’s seed stage.
Turning Assistive Devices into Data Platforms
Headquartered in Linz, Sendance has developed a patented sensor platform designed to integrate directly into orthopedic insoles, prosthetics, and exoskeletons. The technology enables manufacturers to collect real-time health and mobility data, adding a digital intelligence layer to traditionally mechanical devices. By embedding analytics capabilities into assistive equipment, the company aims to help improve patient outcomes and long-term quality of life.
The platform is already being adopted by customers internationally, signaling commercial traction beyond the research phase. Products carrying the “sendance inside” label are now entering the market, marking an important milestone in the company’s transition from development to deployment. The approach positions Sendance within the growing field of personalized and connected medical technologies.
Investor Confidence in Technology and Team
For Garage Angels, the decision to invest was driven by the maturity of the technology and the track record of the founding team. The group cited the scalability and adaptability of Sendance’s solution as key factors in its investment thesis. Personalized and smart medical devices are widely seen as a long-term structural trend in healthcare, reinforcing the strategic rationale behind the deal.
Miloš Dendis of Garage Angels highlighted the importance of execution capability alongside innovation. He pointed to the leadership of founder Robert Koeppe as a decisive element in the investment process. The combination of deep technical expertise and a clear commercial roadmap helped secure investor confidence.
Leadership Shaped by Prior Exit
Sendance is led by Robert Koeppe, a second-time founder with experience in sensor technologies and deep-tech commercialization. He previously founded isiQiri, a company focused on advanced sensing solutions, which he exited through a merger and acquisition transaction in 2018. That background has influenced both the technological direction and strategic positioning of Sendance.
Koeppe brings a product-driven approach to scaling the company, aligning technical innovation with market needs. He stated that the new capital will be directed toward strengthening sales, marketing, and product scaling initiatives. The funding is also expected to accelerate adoption among manufacturers seeking to enhance physical devices with actionable data capabilities.
Funding History and Strategic Outlook
To date, Sendance has raised approximately €2.6 million to support the development of its digital health platform. The latest investment is intended to further refine the company’s sensor technology and broaden its integration across medical and assistive device manufacturers. By enabling data-driven insights in mobility solutions, Sendance is targeting a niche at the intersection of hardware, health analytics, and connected care.
Garage Angels, founded in 2019 in Brno, focuses on pre-seed and seed-stage investments and is composed of experienced entrepreneurs who contribute both capital and operational expertise. The group works closely with regional innovation stakeholders to strengthen the startup ecosystem in Central Europe. Electron Capital Partners, a family investment office linked to the founders of Tescan Group, supports the company as part of its diversified private equity strategy.
The latest investment underscores growing interest in technologies that bridge physical medical devices and digital health intelligence. By embedding sensors and analytics into assistive equipment, Sendance is seeking to redefine how mobility data is captured and utilized. With new capital and experienced backers, the company is positioning itself to scale across international markets and contribute to the evolution of smarter, personalized healthcare solutions.